Apis Capital Advisors’s Insmed INSM Stock Holding History

Apis Capital Advisors’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-22,000	Closed	-$517K	–	31
2022 Q1	$517K	Buy	+22,000	New	+$511K	0.63%	26

Other funds holding INSM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Apis Capital Advisors's INSM Position: Q2 2022 in Review

Apis Capital Advisors sold out of Insmed (INSM) in Q2 2022, closing a stake of 22,000 shares — an estimated $517K sold.

Apis Capital Advisors first reported a position in INSM in Q1 2022 and held it in 1 quarter. The position peaked at $517K in Q1 2022. 214 funds tracked by Wall St. Rank hold INSM as of Q2 2022.

Apis Capital Advisors reported no remaining Insmed position as of Q2 2022 after selling out during the quarter.
Apis Capital Advisors sold 22,000 Insmed shares in Q2 2022, an estimated $517K.
Apis Capital Advisors first reported a position in Insmed in Q1 2022 and held it in 1 quarter.
Apis Capital Advisors's Insmed position peaked at $517K in Q1 2022.
214 funds tracked by Wall St. Rank held Insmed as of Q2 2022.

Based on Apis Capital Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.